The FDA has approved Novartis‘ Exforge HCT (amlodipine/valsartan/hydrochlorothiazide) tablets, a combination product containing a calcium channel blocker, an ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Exforge HCT contains the active ingredients Amlodipine Besilate, ...

EAST HANOVER, N.J., Aug. 4 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved two single-pill combination medications, Diovan HCT(R) (valsartan and hydrochlorothiazide) and Exforge ...

With Teva being the first to file, the company will enjoy 180 days of marketing exclusivity. As per IMS data, Exforge HCT tablets recorded annual sales of approximately $158 million in the U.S. as of ...

Teva announced the launch of Amlodipine, Valsartan, and Hydrochlorothiazide Tablets, the generic version of Novartis‘ Exforge HCT. Exforge HCT contains amlodipine, a calcium channel blocker, valsartan ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. AMLODIPINE/VALSARTAN/HCT NOVARTIS contains the active ingredients ...

Review the side-effects of Amlodipine, Valsartan and Hydrochlorothiazide as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking ...

Novartis has received a major boost in the USA after regulators there gave their backing to two of the Swiss major’s combination high blood-pressure drugs which can now be used as first-line ...

Approvals consistent with current US treatment guidelines to start appropriate patients on combination therapies[1] Up to 80% of patients may need multiple medications to help them reach blood ...

Read the Patient Information Leaflet if available from your pharmacist before you start taking this product and each time you get a refill. If you have any questions, ask your doctor or pharmacist.